Who is sponsoring NCT04553120?

NCT04553120 is sponsored by Universitat Jaume I.

What drugs are being tested in NCT04553120?

Interventions in NCT04553120: Alternating single stimulus and multiple stimuli.

What condition does NCT04553120 study?

NCT04553120 studies Animal Phobia.

Is NCT04553120 still recruiting?

NCT04553120 is currently completed. Last updated 13 May 2024.

Last reviewed 2024-05-13 · How we verify

NCT04553120

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Improving the Exposure Therapy Through Projection-based Augmented Reality for the Treatment of Cockroach Phobia

Completed NA Last updated 13 May 2024

What this trial tests

NA trial testing Alternating single stimulus and multiple stimuli in Animal Phobia in 4 participants. Completed in 30 December 2022.

Timeline

30 September 2020

Primary endpoint
31 December 2020

30 December 2022

Quick facts

Lead sponsor	Universitat Jaume I
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	4
Start date	30 September 2020
Primary completion	31 December 2020
Estimated completion	30 December 2022
Sites	1 location across Spain

Drugs / interventions tested

Alternating single stimulus and multiple stimuli

Conditions studied

Animal Phobia — all drugs for Animal Phobia →

Sponsor

Universitat Jaume I — full company profile →

Who can join

18 and older, any sex, with Animal Phobia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to test the efficacy and efficiency of varying the phobic stimuli during the augmented reality (AR) exposure therapy using multiple stimuli versus one single stimulus through projection-based AR (P-ARET) for the treatment of participants diagnosed with cockroach phobia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Universitat Jaume I trials

Trials by the same sponsor.

NCT07202975 — RE-SCALE: Rehabilitation Engagement and Scaled Access With eXtended Reality and Artificial Intelligence · NA · not yet recruiting
NCT07345117 — Cost-effectiveness and Implementation of a Transdiagnostic Internet-based Intervention for Emotional Disorders in Commun · NA · not yet recruiting
NCT06932120 — Technology-supported Interventions for Prolonged Grief Disorder (PGD) · NA · recruiting
NCT06788119 — Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders · NA · recruiting
NCT06839573 — Effectiveness of Immersive Virtual Reality in Nursing Students' Learning · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04553120 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universitat Jaume I
Last refreshed: 13 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04553120.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing